COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive… (NCT04433325) | Clinical Trial Compass
CompletedNot Applicable
COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units
France37 participantsStarted 2020-07-30
Plain-language summary
Since early 2020, France knows a sanitary crisis with a massive influx of COVID-19 patients admitted in Intensive Care Units (ICU). It led to a saturation of the French health system, especially in some geographic areas such as East of France or Paris region. Therefore, authorities decided to transfer some critically ill patients from these crowded ICUs to less busy regional ICUs. it was done for the first time by medical train transportation. Knowing that the investigators lack experience regarding this type of medical evacuation, regarding the high number of transferred patients, with such a logistic effort, the investigators decided to study this phase of the COVID-19 sanitary crisis in order to draw a feedback. So far, there are no data in the literature regarding this topic.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \> 18 years
* COVID-19 positive patients admitted in Intensive Care Unit between 15/03/2020 and 15/04/2020
* Patients (or legal representative) with no opposition to inclusion in medical research protocol
* Regarding case group : Patients transferred from Paris's ICU
* Regarding case control group : Patients admitted in ICU with no transfer from Paris
Exclusion Criteria:
\- \> 18 years under legal protection and patients with liberty restriction
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study tracked critically ill COVID-19 patients who were transported by train from Paris ICUs to ICUs in western France — if I or my loved one is in a similar situation of ICU overflow, is inter-hospital or inter-regional transport by train something that might be considered, and what are the risks involved?
2The primary outcome this study measured was the number of deaths after medical train transport — what did the results suggest about survival rates for critically ill COVID-19 patients who underwent this kind of long-distance transfer, and how might that inform decisions about moving a patient between ICUs?
3Since this trial has no assigned phase and involved a real-world emergency transport operation rather than a controlled drug or device test, how reliable are its findings for guiding decisions about a specific patient's transport today?
4If a patient needed to be moved out of an overwhelmed ICU during a COVID-19 surge, what alternatives to long-distance train transport exist, and how does the risk of transport compare to staying in an at-capacity unit?
5This study focused on 'ICU syndrome' as a condition alongside COVID-19 — can you explain what ICU syndrome is, how it might affect recovery after a long transport like this, and whether it's something we should be monitoring for?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
number of death
Timeframe: at Intensive Care Units discharge, an average of 1 months